BOARD OF DIRECTORS

The Cancer Research & Treatment Fund (CR&T) is led by a Board of Directors that is supported by our Medical Advisory Board.  Together, they represent a broad cross-section of specialties and disciplines, working together to rapidly deploy funding to the frontlines of research and ensuring CR&T maintains its reputation as a leading voice in cancer research.

 
Thomas M. Silver, President

COO, Bright Funds

 

Richard T. Silver, MD, Vice President, Medical Director

New York-Presbyterian/Weill Cornell Medicine

 

Joseph N. Aimi

President, Kenneth Bieber, Inc.

 

Henry J. Amoroso, Esq.

Partner, Chiesa Shahinian & Giantomasi PC

 

David T. Boule

Retired Partner, Ernst & Young

 

Maria Brisbane, CFA

Managing Director, Merrill Lynch

 

Steven Elkes

Trustee, Elkes Foundation

 

Terry Hermanson

President, Mr. Christmas, Inc.

 

Jay J. Hochfelsen, JD

President, Compass Benefit Planning

 

Michael C. Kempner

Managing General Partner, KS Capital Partners, LP

 

Douglas W. McCormick

Board President, Rho Capital Partners, LP

 

Kasia McCormick
 
Amanda Johns Perez
 
Richard J. Rose

Sr. Managing Director, Retired, Shufro, Rose & Co., LLC

 

Todd J. Shaw

Senior Vice President, Morgan Stanley

 

AJ Shiekman

Strategy/Business Development Manager, Pure Storage

 

Adam Silver

Sr. Managing Member, Bennett Management

 

Tim Silver

Associate, Lazard Asset Management, LLC

 

Anne Templeton
 

Counsel

 
Nelson A. Boxer

Petrillo Klein & Boxer LLP